CAS 532414-36-1

Formoterol Related Compound I (N-(2-hydroxy-5-[(RS)-1-hydroxy-2-{[(SR)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl)formamide)

CAS: 532414-36-1

Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof

Formel: C₁₉H₂₄N₂O₄

Farbe und Form: Off-White Solid

Molekulargewicht: 344.17361

Ref: 45-1286184

Formoterol EP Impurity I-13C-d3

CAS: 532414-36-1

Formel: C₁₈₁₃CH₂₁D₃N₂O₄

Molekulargewicht: 348.42

Ref: 4Z-F-11103

Formoterol EP Impurity I (Formoterol USP Related Compound I)

CAS: 532414-36-1

Formel: C₁₉H₂₄N₂O₄

Farbe und Form: White To Off-White Solid

Molekulargewicht: 344.41

Ref: 4Z-F-1118

Formoterol EP Impurity I

CAS: 532414-36-1

Formel: C₁₉H₂₄N₂O₄

Molekulargewicht: 344.41

Ref: ST-EA-CP-F42058

rel-(R,S)-Formoterol

CAS: 532414-36-1

Applications rel-(R,S)-Formoterol is a stereoisomer of Formoterol (F693395). Formoterol is a long-acting inhaled beta-2 agonist (bronchodilator) that is used to treat patients with COPD and asthma.
References Cazzola, M., et al.: CHEST J., 114, 411 (1998); Kips, J., et al.: Am. J. Resp. Crit. Care Med., 161, 996 (2000); O’Byrne, P., et al.: Am. J. Rest. Crit. Care Med., 164, 1392 (2001)

Formel: C₁₉H₂₄N₂O₄

Farbe und Form: Neat

Molekulargewicht: 344.405

Ref: TR-F693435

Rel-(R,S)-formoterol

Kontrolliertes Produkt

CAS: 532414-36-1

Rel-(R,S)-formoterol is a medicinal compound that has shown promising results in the inhibition of cancer cell growth. It is derived from Chinese medicinal plants and has been tested on human cancer cell lines. Rel-(R,S)-formoterol works by inhibiting kinase activity, which is involved in regulating the cell cycle and preventing apoptosis. By inhibiting this activity, Rel-(R,S)-formoterol induces apoptosis and leads to cell death in cancer cells. This compound also acts as a protein inhibitor, preventing the formation of protein complexes that are essential for cancer cell survival. In addition, Rel-(R,S)-formoterol has been detected in urine samples of patients undergoing cancer treatment, indicating its potential use as a therapeutic agent.

Formel: C₁₉H₂₄N₂O₄

Reinheit: Min. 95%

Molekulargewicht: 344.4 g/mol

Ref: 3D-HWA41436